BIOCRYST SCHEDULED TO PRESENT AT THE NEEDHAM & COMPANY THIRD ANNUAL BIOTECHNOLOGY CONFERENCE

June 11, 2004
BIOCRYST SCHEDULED TO PRESENT AT THE NEEDHAM & COMPANY THIRD ANNUAL BIOTECHNOLOGY CONFERENCEBirmingham, Alabama - June 11, 2004 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) announced that Charles E. Bugg, Ph.D., Chairman and CEO, will be presenting at the Needham & Company Third Annual Biotechnology Conference on Wednesday, June 16, 2004, at 2:30 p.m. Eastern Daylight Time. Interested investors can listen to the presentation live over the Internet during the conference at the following address:

What:
BioCryst Pharmaceuticals, Inc. Presentation at the Needham & Company Third Annual Biotechnology Conference

When:
Wednesday, June 16, 2004, at 2:30 p.m. EDT

Where:
http://www.wsw.com/webcast/needham8/bcrx/

How:
Live over the Internet -- Simply log on to the web at the address above

For those unable to listen at the designated time, the webcast will remain available for replay on http://www.wsw.com/webcast/needham8/bcrx/ for 90 days following the conference.

Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases, and viral infections.